Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia
Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia have?
Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia has 209 citations in the OpenAlex counts ScholarIQ stores.
When was Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia published?
Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia has 2018 year in the ScholarIQ index.
What is the open-access status of Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia?
Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia has gold oa status in the ScholarIQ index.
What is the DOI of Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia?
The DOI for Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia is on the source record.
What is the PMID of Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia?
The PMID for Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia is on the source record.
What is the OpenAlex record for Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia?
The OpenAlex for Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia is on the source record.